Mitochondrial regulation of epigenetics and its role in human diseases

Epigenetics

Volumn 7, Issue 4, 2012, Pages 326-334

  Minocherhomji, Sheroy ^a   Tollefsbol, Trygve O ^b   Singh, Keshav K ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

DNA methylation; Epigenetics; Epigenome; Mitocheckpoint; Mitochondria; OXPHOS

Indexed keywords

GENOMIC DNA; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; MITOCHONDRIAL DNA; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

ARTICLE; CANCER SUSCEPTIBILITY; CELL NUCLEUS; CHROMATIN STRUCTURE; CPG ISLAND; DNA METHYLATION; DNA REPLICATION; DNA TRANSCRIPTION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; GENOTYPE; GERM LINE; HETEROPLASMY; HISTONE MODIFICATION; HUMAN; MITOCHONDRION; MOLECULAR INTERACTION; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PHENOTYPE;

EID: 84860586157     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.19547     Document Type: Article

References (107)

1. Singh KK. Mitochondrial DNA mutations in aging, disease and cancer. New York: Springer, 1998.
2. Singh KK, Costello C. Mitochondria and Human Cancer. New York: Springer, 2008.
3. Chandra D, Singh KK. Genetic insights into OXPHOS defect and its role in cancer. Biochim Biophys Acta 2010; 1807:620-5 PMID:21074512.
4. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007; 1775:138-62 PMID:17045745.
5. Smiraglia DJ, Kulawiec M, Bistulfi GL, Gupta SG, Singh KK. A novel role for mitochondria in regulating epigenetic modification in the nucleus. Cancer Biol Ther 2008; 7:1182-90 PMID:18458531; http://dx.doi.org/10.4161/cbt.7.8.6215.
6. Xie CH, Naito A, Mizumachi T, Evans TT, Douglas MG, Cooney CA, et al. Mitochondrial regulation of cancer associated nuclear DNA methylation. Biochem Biophys Res Commun 2007; 364:656-61 PMID:17964537; http://dx.doi.org/10.1016/j.bbrc.2007.10.047.
7. Chatterjee AME, Mambo E, Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene 2006; 25:4663-74 PMID:16892080; http://dx.doi.org/10.1038/sj.onc.1209604.
8. Bianchi NO, Bianchi MS, Richard SM. Mitochondrial genome instability in human cancers. Mutat Res2001; 488:9-23 PMID:11223402; http://dx.doi.org/10.1016/S1383-5742(00)00063-6.
9. Taanman J. The mitochondrial genome: structure, transcription, translation and replication. Biochimica et Biophysica Acta (BBA). Bioenergetics 1999; 1410:103-23 http://dx.doi.org/10.1016/S0005-2728(98)00161-3.
10. Schatz G. The protein import system of mitochondria. J Biol Chem 1996; 271:31763-6 PMID:8943210.
11. Alberio S, Mineri R, Tiranti V, Zeviani M. Depletion of mtDNA: syndromes and genes. Mitochondrion 2007; 7:6-12 PMID:17280874; http://dx.doi.org/10.1016/j.mito.2006.11.010.
12. Kulawiec M, Owens KM, Singh KK. mt DNAG10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice. J Hum Genet 2009; 54:647-654 PMID: 19763141; http://dx.doi.org/doi:10.1038/jhg.2009.89.
13. Modica-Napolitano JS, Singh KK. Mitochondrial dysfunction in cancer. Mitochondrion 2004; 4:755-62 PMID:16120430; http://dx.doi.org/10.1016/j.mito.2004.07.027.
14. Kulawiec M, Ayyasamy V, Singh KK. p53 regulates mtDNA copy number and mitocheckpoint pathway. J Carcinog 2009; 8:8 PMID:19439913; http://dx.doi.org/10.4103/1477-3163.50893.
15. Selvanayagam P, Rajaraman S. Detection of mitochondrialgenome depletion by a novel cDNA in renal cell carcinoma. Lab Invest 1996; 74:592-9 PMID:8600309.
16. Lee MS, Yuet-Wa JC, Kong SK, Yu B, Eng-Choon VO, Nai-Ching HW, et al. Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft. Cancer Biol Ther 2005; 4:1248-54 PMID:16258257; http://dx.doi.org/10.4161/cbt.4.11.2136.
17. Yin PH, Lee HC, Chau GY, Wu YT, Li SH, Lui WY, et al. Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer 2004; 90:2390-6 PMID:15150555.
18. Wu H, Chen Y, Liang J, Shi B, Wu G, Zhang Y, et al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 2005; 438:981-7 PMID:16355216; http://dx.doi.org/10.1038/nature04225
19. Singh KK, Kulawiec M, Still I, Desouki MM, Geradts J, Matsui SI. Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 2005; 354:140-6 PMID:15979824; http://dx.doi.org/10.1016/j.gene.2005.03.027.
20. Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW, Lee LM, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer 2006; 45:629-38 PMID:16568452; http://dx.doi.org/10.1002/gcc.20326.
21. Clayton DA, Vinograd J. Circular dimer and catenate forms of mitochondrial DNA in human leukaemic leucocytes. Nature 1967; 216:652-7 PMID:6082459; http://dx.doi.org/10.1038/216652a0.
22. Delsite R, Kachhap S, Anbazhagan R, Gabrielson E, Singh KK. Nuclear genes involved in mitochondriatonucleus communication in breast cancer cells. Mol Cancer 2002; 1:6 PMID:12495447; http://dx.doi.org/10.1186/1476-4598-1-6.
23. Pello R, Martín MA, Carelli V, Nijtmans LG, Achilli A, Pala M, et al. Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum Mol Genet 2008; 17:4001-11 PMID:18806273; http://dx.doi.org/10.1093/hmg/ddn303.
24. Suissa S, Wang Z, Poole J, Wittkopp S, Feder J, Shutt TE, et al. Ancient mtDNA genetic variants modulate mtDNA transcription and replication. PLoS Genet 2009; 5:1000474 PMID:19424428; http://dx.doi.org/10.1371/journal.pgen.1000474.
25. Verma M, Kumar D. Application of mitochondrial genome information in cancer epidemiology. Clin Chim Acta 2007; 383:41-50 PMID:17532310; http://dx.doi.org/10.1016/j.cca.2007.04.018.
26. Verma M, Naviaux RK, Tanaka M, Kumar D, Franceschi C, Singh KK. Meeting report: mitochondrial DNA and cancer epidemiology. Cancer Res 2007; 67:437-9 PMID:17213255; http://dx.doi.org/10.1158/0008-5472.CAN-06-4119.
27. Booker LM, Habermacher GM, Jessie BC, Sun QC, Baumann AK, Amin M, et al. North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 2006; 175:468-72 PMID:16406974; http://dx.doi.org/10.1016/S0022-5347(05)00163-1.
28. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. Mitochondrial genetic background modifies breast cancer risk. Cancer Res 2007; 67:4687-94 PMID:17510395; http://dx.doi.org/10.1158/0008-5472.CAN-06-3554.
29. Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, et al. Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16:1455-9 PMID:17627010; http://dx.doi.org/10.1158/1055-9965.EPI-07-0119.
30. Canter JA, Kallianpur AR, Parl FF, Millikan RC. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 2005; 65:8028-33 PMID:16140977.
31. Hall IJ, Moorman PG, Millikan RC, Newman B. Comparative analysis of breast cancer risk factors among African-American women and White women. Am J Epidemiol 2005; 161:40-51 PMID:15615914; http://dx.doi.org/10.1093/aje/kwh331.
32. Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett 2007; 249:249-55 PMID:17081685; http://dx.doi.org/10.1016/j.canlet.2006.09.005.
33. Shock LS, Thakkar PV, Peterson EJ, Moran RG, Taylor SM. DNA methyltransferase 1, cytosine methylation and cytosine hydroxymethylation in mammalian mitochondria. Proceedings of the National Academy of Sciences 2011; 108:3630-5
34. Barrès R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 2009; 10:189-98 PMID:19723495; http://dx.doi.org/10.1016/j.cmet.2009.07.011.
35. Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J 1998; 17:4905-8 PMID:9724627; http://dx.doi.org/10.1093/emboj/17.17.4905.
36. Bergman Y, Cedar H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nat Rev Immunol 2004; 4:753-61 PMID:15459667; http://dx.doi.org/10.1038/nri1458.
37. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002; 3:662-73 PMID:12209141; http://dx.doi.org/10.1038/nrg887.
38. Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009; 324:929-30 PMID:19372393; http://dx.doi.org/10.1126/science.1169786.
39. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324:930-5 PMID:19372391; http://dx.doi.org/10.1126/science.1170116.
40. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001; 293:1068-70 PMID:11498573; http://dx.doi.org/10.1126/science.1063852.
41. Li X, Wang X, He K, Ma Y, Su N, He H, et al. Highresolution mapping of epigenetic modifications of the rice genome uncovers interplay between DNA methylation, histone methylation and gene expression. Plant Cell 2008; 20:259-76 PMID:18263775; http://dx.doi.org/10.1105/tpc.107.056879.
42. Lin JC, Jeong S, Liang G, Takai D, Fatemi M, Tsai YC, et al. Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 2007; 12:432-44 PMID:17996647; http://dx.doi.org/10.1016/j.ccr.2007.10.014.
43. Lee JT. Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev 2009; 23:1831-42 PMID:19684108; http://dx.doi.org/10.1101/gad.1811209.
44. Nagano T, Mitchell JA, Sanz LA, Pauler FM, FergusonSmith AC, Feil R, et al. The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 2008; 322:1717-20 PMID:18988810; http://dx.doi.org/10.1126/science.1163802.
45. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5 hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010; 466:1129-33 PMID:20639862; http://dx.doi.org/10.1038/nature09303.
46. Xu Y, Wu F, Tan L, Kong L, Xiong L, Deng J, et al. Genome-wide regulation of 5 hmC, 5mC and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 2011; 42:451-64 PMID:21514197; http://dx.doi.org/10.1016/j.molcel.2011.04.005.
47. Williams K, Christensen J, Pedersen MT, Johansen JV, Cloos PAC, Rappsilber J, et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011; 473:343-8 PMID:21490601; http://dx.doi.org/10.1038/nature10066.
48. De Smet C, Lurquin C, Lethé B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ lineand tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999; 19:7327-35 PMID:10523621.
49. Ezzeldin HH, Lee AM, Mattison LK, Diasio RB. Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients. Clin Cancer Res 2005; 11:8699-705 PMID:16361556; http://dx.doi.org/10.1158/1078-0432.CCR-05-1520
50. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypoand hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178-86 PMID:19151715; http://dx.doi.org/10.1038/ng.298.
51. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008; 68:5049-58 PMID:18593903; http://dx.doi.org/10.1158/0008-5472.CAN-07-6655.
52. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31:766-76 PMID:19843643; http://dx.doi.org/10.1093/carcin/bgp250.
53. Langevin SM, Stone RA, Bunker CH, Grandis JR, Sobol RW, Taioli E. MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index. Carcinogenesis 2010; 31:864-70 PMID:20197299; http://dx.doi.org/10.1093/carcin/bgq051.
54. Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, et al. S-Adenosylmethionine and methylation. FASEB J 1996; 10:471-80 PMID:8647346.
55. Wallace DC, Fan W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion 2010; 10:12-31 PMID:19796712; http://dx.doi.org/10.1016/j.mito.2009.09.006.
56. Ulrey CL, Liu L, Andrews LG, Tollefsbol TO. The impact of metabolism on DNA methylation. Hum Mol Genet 2005; 14:139-47 PMID:15809266; http://dx.doi.org/10.1093/hmg/ddi100.
57. Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, Catchpoole D, et al. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 2005; 92:1574-80 PMID:15798773; http://dx.doi.org/10.1038/sj.bjc.6602478.
58. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003; 299:1753-5 PMID:12637750; http://dx.doi.org/10.1126/science.1080902.
59. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8:286-98 PMID:17339880; http://dx.doi.org/10.1038/nrg2005.
60. Feinberg AP. Genomic imprinting and gene activation in cancer. Nat Genet 1993; 4:110-3 PMID:8348145; http://dx.doi.org/10.1038/ng0693-110.
61. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005; 37:391-400 PMID:15765097; http://dx.doi.org/10.1038/ng1531.
62. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009; 324:1076-80 PMID:19461003; http://dx.doi.org/10.1126/science.1164097.
63. Barile M, Brizio C, Valenti D, De Virgilio C, Passarella S. The riboflavin/FAD cycle in rat liver mitochondria. Eur J Biochem 2000; 267:4888-900 PMID:10903524; http://dx.doi.org/10.1046/j.1432-327.2000.01552.x.
64. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004 119:941-53; PMID:15620353; http://dx.doi.org/10.1016/j.cell.2004.12.012
65. Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu W, et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 2009; 138:660-72 PMID:19703393; http://dx.doi.org/10.1016/j.cell.2009.05.050.
66. Lee JS, Smith E, Shilatifard A. The language of histone crosstalk. Cell 2010; 142:682-5 PMID:20813257; http://dx.doi.org/10.1016/j.cell.2010.08.011.
67. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293:1074-80 PMID:11498575; http://dx.doi.org/10.1126/science.1063127.
68. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823-37 PMID:17512414; http://dx.doi.org/10.1016/j.cell.2007.05.009.
69. Schones DE, Zhao K. Genome-wide approaches to studying chromatin modifications. Nat Rev Genet 2008; 9:179-91 PMID:18250624; http://dx.doi.org/10.1038/nrg2270.
70. Rice JC, Allis CD. Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr Opin Cell Biol 2001; 13:263-73 PMID:11343896; http://dx.doi.org/10.1016/S0955-0674(00)00208-8.
71. Minocherhomji S, Madon PF, Parikh FR. Epigenetic regulatory mechanisms associated with infertility. Obstet Gynecol Int 2010; 2010:2010 PMID:20814440; http://dx.doi.org/10.1155/2010/198709.
72. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008; 40:897-903 PMID:18552846; http://dx.doi.org/10.1038/ng.154.
73. Bannister AJ, Schneider R, Kouzarides T. Histone methylation: dynamic or static? Cell 2002; 109:801-6 PMID:12110177; http://dx.doi.org/10.1016/S0092-8674(02)00798-5.
74. Shahbazian MD, Grunstein M. Functions of sitespecific histone acetylation and deacetylation. Annu Rev Biochem 2007; 76:75-100 PMID:17362198; http://dx.doi.org/10.146/annurev.biochem.76.052705.162114.
75. Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu Rev Biochem 2001; 70:81-120 PMID:11395403; http://dx.doi.org/10.1146/annurev.biochem.70.1.81.
76. Swigut T, Wysocka J. H3K27 demethylases, at long last. Cell 2007; 131:29-32 PMID:17923085; http://dx.doi.org/10.1016/j.cell.2007.09.026.
77. Koehntop KD, Emerson JP, Que L Jr. The 2-His-1carboxylate facial triad: a versatile platform for dioxygen activation by mononuclear non-heme iron(II) enzymes. J Biol Inorg Chem 2005; 10:87-93; PMID:15739104 http://dx.doi.org/10.1007/s00775-005-0624-x.
78. Agger K, Cloos PAC, Christensen J, Pasini D, Rose S, Rappsilber J, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007; 449:731-4 PMID:17713478; http://dx.doi.org/10.1038/nature06145.
79. Berkich DA, Xu Y, LaNoue KF, Gruetter R, Hutson SM. Evaluation of brain mitochondrial glutamate and alphaketoglutarate transport under physiologic conditions. J Neurosci Res 2005; 79:106-13 PMID:15558751; http://dx.doi.org/10.1002/jnr.20325.
80. Gibson GE, Starkov A, Blass JP, Ratan RR, Beal MF. Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim Biophys Acta 2010; 1802:122-34 PMID:19715758
81. Sisková Z, Mahad DJ, Pudney C, Campbell G, Cadogan M, Asuni A, et al. Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease. Am J Pathol 2010; 177:1411-21 PMID:20651247; http://dx.doi.org/10.2353/ajpath.2010.091037.
82. Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, Stahl E, et al. Integrated analysis of protein composition, tissue diversity and gene regulation in mouse mitochondria. Cell 2003; 115:629-40 PMID:14651853; http://dx.doi.org/10.1016/S0092-8674(03)00926-7.
83. Singh KK. Mitochondria damage checkpoint in apoptosis and genome stability. FEMS Yeast Res 2004; 5:127-32 PMID:15489195; http://dx.doi.org/10.1016/jfemsyr.2004.04.008.
84. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196:261-82 PMID:3656447; http://dx.doi.org/10.1016/0022-2836(87)90689-9.
85. Smiraglia DJ, Kazhiyur-Mannar R, Oakes CC, Wu YZ, Liang P, Ansari T, et al. Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations. BMC Genomics 2007; 8:446 PMID:18053125; http://dx.doi.org/10.1186/1471-2164-8-446.
86. Liu L, van Groen T, Kadish I, Li Y, Wang D, James S, et al. Insufficient DNA methylation affects healthy aging and promotes age-related health problems. Clinical Epigenetics 2011; 1-12.
87. Rhee I, Bachman KE, Park BH, Jair KW, Yen RWC, Schuebel KE, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002; 416:552-6 PMID:11932749; http://dx.doi.org/10.1038/416552a.
88. Dakubo G. Functional Importance of Mitochondrial Genetic Alterations in Cancer. Mitochondrial Genetics and Cancer 2010; 213-36.
89. Xie CH, Naito A, Mizumachi T, Evans TT, Douglas MG, Cooney CA, et al. Mitochondrial regulation of cancer associated nuclear DNA methylation. Biochem Biophys Res Commun 2007; 364:656-61 PMID:17964537; http://dx.doi.org/10.1016/j.bbrc.2007.10.047.
90. Iijima-Ando K, Hearn SA, Shenton C, Gatt A, Zhao L, Iijima K. Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease. PLoS One 2009; 4:8310 PMID:20016833; http://dx.doi.org/10.1371/journal.pone.0008310.
91. Takasugi M, Yagi S, Hirabayashi K, Shiota K. DNA methylation status of nuclear-encoded mitochondrial genes underlies the tissue-dependent mitochondrial functions. BMC Genomics 2010; 11:481 PMID:20723256; http://dx.doi.org/10.1186/1471-2164-11-481.
92. Delsite RL, Rasmussen LJ, Rasmussen AK, Kalen A, Goswami PC, Singh KK. Mitochondrial impairment is accompanied by impaired oxidative DNA repair in the nucleus. Mutagenesis 2003; 18:497-503 PMID:14614184; http://dx.doi.org/10.1093/mutage/geg027.
93. Rasmussen AK, Chatterjee A, Rasmussen LJ, Singh KK. Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae. Nucleic Acids Res 2003; 31:3909-17 PMID:12853606; http://dx.doi.org/10.1093/nar/gkg446.
94. Kunz BA, Kohalmi SE. Modulation of mutagenesis by deoxyribonucleotide levels. Annu Rev Genet 1991; 25:339-59 PMID:1812810; http://dx.doi.org/10.1146/annurev.ge.25.120191.002011.
95. Bebenek K, Kunkel TA. Frameshift errors initiated by nucleotide misincorporation. Proc Natl Acad Sci USA 1990; 87:4946-50 PMID:2195542; http://dx.doi.org/10.1073/pnas.87.13.4946
96. Jacky PB, Beek B, Sutherland GR. Fragile sites in chromosomes: possible model for the study of spontaneous chromosome breakage. Science 1983; 220:69-70 PMID:6828880; http://dx.doi.org/10.1126/science.6828880.
97. Reichard P. Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem 1988; 57:349-74 PMID:3052277; http://dx.doi.org/10.1146/annurev.bi.57.070188.002025.
98. Desler C, Munch-Petersen B, Stevnsner T, Matsui S, Kulawiec M, Singh KK, et al. Mitochondria as determinant of nucleotide pools and chromosomal stability. Mutat Res 2007; 625:112-24 PMID:17658559; http://dx.doi.org/10.1016/j.mrfmmm.2007.06.002.
99. Stumpf JD, Copeland WC. Mitochondrial DNA replication and disease: insights from DNA polymerase gamma mutations. Cell Mol Life Sci 2010; 68:219-33 PMID:20927567
100. Singh KK. Mitochondria damage checkpoint, aging and cancer. Ann NY Acad Sci 2006; 1067:182-90 PMID:16803984; http://dx.doi.org/10.1196/annals.1354.022.
101. Park SY, Chang I, Kim JY, Kang SW, Park SH, Singh K, et al. Resistance of mitochondrial DNAdepleted cells against cell death: role of mitochondrial superoxide dismutase. J Biol Chem 2004; 279:7512-20 PMID:14660625; http://dx.doi.org/10.1074/jbc.M307677200.
102. Kulawiec M, Arnouk H, Desouki MM, Kazim L, Still I, Singh KK. Proteomic analysis of mitochondria-tonucleus retrograde response in human cancer. Cancer Biol Ther 2006; 5:967-75 PMID:16775426; http://dx.doi.org/10.4161/cbt.5.8.2880.
103. Sharpless NE, DePinho RA. Cancer: crime and punishment. Nature 2005; 436:636-7 PMID:16079829; http://dx.doi.org/10.1038/436636a
104. Collado M, Serrano M. The senescent side of tumor suppression. Cell Cycle 2005; 4:1722-4 PMID:16294043; http://dx.doi.org/10.4161/cc.4.12.2260.
105. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, et al. BRAFE600associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436:720-4 PMID:16079850; http://dx.doi.org/10.1038/nature03890.
106. Dimri GP. What has senescence got to do with cancer? Cancer Cell 2005; 7:505-12 PMID:15950900; http://dx.doi.org/10.1016/j.ccr.2005.05.025.
107. Naviaux RK. Mitochondrial control of epigenetics. Cancer Biol Ther 2008; 7:1191-3 PMID:18719362; http://dx.doi.org/10.4161/cbt.7.8.6741